...
首页> 外文期刊>World journal of urology >Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
【24h】

Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.

机译:小肾肿块(<4 cm)中肿瘤细胞瘤和肾细胞癌的分化:4相计算机断层扫描的作用。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: We investigate the use of 4-phase computerized tomography with intravenous contrast to help distinguish oncocytoma from renal cell carcinoma (RCC) in tumors <4 cm. METHODS: We retrospectively identified patients who underwent surgical management for renal tumors <4 cm from 2005 to 2008. Patients who had pre-operative CT evaluation as per our institution's renal mass protocol and had confirmed pathological diagnosis of either oncocytoma or RCC were included in the study. Enhancement readings were obtained for the tumor and the renal cortex using the same slice simultaneously. RESULTS: Our cohort involved 69 patients (46 men, 23 women; mean age 66) who presented with 79 renal masses. Histopathologically 40 were clear cell, 22 papillary, 5 chromophobe RCC and 12 oncocytoma. On the arterial, venous and delayed phase images, oncocytoma showed the highest mean enhancement change, i.e.,546, 396 and 239% followed by clear cell RCC 261, 261 and 174%, chromophobe RCC 147, 127 and 66% and papillary RCC 137, 184 and 118%, respectively. The enhancement pattern differed significantly on comparing oncocytoma with RCC (P < 0.007). The mean percentage contrast excreted at the end of the delayed phase was 33.3, 13.8, 32 and 53% for clear cell, papillary, chromophobe and oncocytoma, respectively. CONCLUSION: The enhancement and washout values in Hounsfield units obtained by multiphasic CT scan aid in distinguishing oncocytoma from the commonly seen subtypes of RCC in renal masses <4 cm. This preliminary study demonstrates that arterial phase enhancement greater than 500% and washout values of greater than 50% are exclusively seen in renal oncocytomas.
机译:目的:我们研究了静脉造影的4相计算机断层扫描技术的使用,以帮助区分<4 cm肿瘤中的肿瘤细胞瘤与肾细胞癌(RCC)。方法:我们回顾性分析了从2005年至2008年接受外科手术治疗的小于4 cm肾肿瘤的患者。根据我们机构的肾脏质量规程进行术前CT评估并已确认肿瘤细胞瘤或RCC的病理诊断的患者包括在研究中。研究。同时使用同一切片获得肿瘤和肾皮质的增强读数。结果:我们的队列包括69名患者(46名男性,23名女性;平均年龄66岁),其中有79个肾脏肿块。在组织病理学上40例为透明细胞,22例为乳头状,5例为发色RCC,12例为细胞瘤。在动脉,静脉和延迟相图像上,肿瘤细胞瘤表现出最高的平均增强变化,即546、396和239%,其次是透明细胞RCC 261、261和174%,生色团RCC 147、127和66%以及乳头RCC 137 ,分别为184%和118%。在将细胞瘤与RCC进行比较时,增强模式有显着差异(P <0.007)。延迟期末排泄的透明细胞,乳头状瘤,生色团和瘤细胞瘤的平均造影剂百分比分别为33.3、13.8、32和53%。结论:通过多相CT扫描获得的Hounsfield单位的增强值和清除值有助于区分<4 cm的肾脏肿块中的癌细胞瘤与常见的RCC亚型。这项初步研究表明,仅在肾上皮细胞瘤中可见动脉期增强大于500%,洗脱值大于50%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号